You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Avamys Nasal Spray Device

Avamys Nasal Spray 

Avamys nasal spray is indicated for the treatment of the symptoms of allergic rhinitis in adults, adolescents and children (aged 6 and over) 1

Reference:

  1. Avamys Summary of product Characteristics Available from www.medicines.ie last accessed July 2020

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to the HPRA Pharmacovigilance, Earlsfort Terrace, Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; e-mail:medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

Avamys is a registered trademark of the GlaxoSmithKline group of companies.